Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics

References

• Liu S, Guo R, Simpson LG, et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003;278(39):37419-26
   PubMed Web of Science ®Google Scholar
• Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 2003;285(1):E1-9
   Web of Science ®Google Scholar
• Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006;38(11):1310-15
   PubMed Web of Science ®Google Scholar
• Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007;18(6):1637-47
   PubMed Web of Science ®Google Scholar
• Liu S, Zhou J, Tang W, et al. Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab 2008;295(2):E254-61
   Web of Science ®Google Scholar
• Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 2008;118(12):3820-8
   PubMed Web of Science ®Google Scholar
• Martin A, Quarles LD. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis. Adv Exp Med Biol 2012;728:65-83
   PubMed Web of Science ®Google Scholar
• Quarles LD. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 2012;8(5):276-86
   PubMed Web of Science ®Google Scholar
• Xiao Z, Huang J, Cao L, et al. Osteocyte-specific deletion of Fgfr1 suppresses FGF23. Plos One 2014;9(8):e104154
   Web of Science ®Google Scholar
• Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006;6(2):93-106
   PubMed Web of Science ®Google Scholar
• Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466(7308):829-34
   PubMed Web of Science ®Google Scholar
• Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature 2014;505(7483):327-34
   PubMed Web of Science ®Google Scholar
• Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol 2008;3(Suppl 3):S131-9
   PubMed Web of Science ®Google Scholar
• Frost HM. Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res 1969;3(3):211-37
   PubMedGoogle Scholar
• Mika C, Holtkamp K, Heer M, et al. A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa. J Neural Transm 2007;114(12):1611-18
   PubMed Web of Science ®Google Scholar
• Audi L, Vargas DM, Gussinyé M, et al. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa. Pediatr Res 2002;51(4):497-504
   PubMed Web of Science ®Google Scholar
• Soyka LA, Grinspoon S, Levitsky LL, et al. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999;84(12):4489-96
   PubMed Web of Science ®Google Scholar
• Jacoangeli F, Zoli A, Taranto A, et al. Osteoporosis and anorexia nervosa: relative role of endocrine alterations and malnutrition. Eat Weight Disord 2002;7(3):190-5
   PubMedGoogle Scholar
• Misra M, Miller KK, Bjornson J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003;88(12):5615-23
   PubMed Web of Science ®Google Scholar
• Misra M, Katzman DK, Cord J, et al. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 2008;93(8):3029-36
   PubMed Web of Science ®Google Scholar
• Misra M, Klibanski A. Bone metabolism in adolescents with anorexia nervosa. J Endocrinol Invest 2011;34(4):324-32
   PubMed Web of Science ®Google Scholar
• Misra M, Klibanski A. Anorexia nervosa, obesity and bone metabolism. Pediatr Endocrinol Rev 2013;11(1):21-33
   PubMedGoogle Scholar
• Fazeli PK, Klibanski A. Bone metabolism in anorexia nervosa. Curr Osteoporos Rep 2014;12(1):82-9
   PubMed Web of Science ®Google Scholar
• Himes JH. Bone growth and development in protein-calorie malnutrition. World Rev Nutr Diet 1978;28:143-87
   PubMedGoogle Scholar
• Faridi MM, Ansari Z, Bhargava SK. Imprints of protein energy malnutrition on the skeleton of children. J Trop Pediatr 1984 30(3):150-3
   Google Scholar
• Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100(2):197-207
   PubMed Web of Science ®Google Scholar
• Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002;111(3):305-17
   PubMed Web of Science ®Google Scholar
• Elefteriou F, Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005;434(7032):514-20
   PubMed Web of Science ®Google Scholar
• Fu L, Patel MS, Bradley A, et al. The molecular clock mediates leptin-regulated bone formation. Cell 2005;122(5):803-15
   PubMed Web of Science ®Google Scholar
• Shi Y, Yadav VK, Suda N, et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci USA 2008;105(51):20529-33
   PubMed Web of Science ®Google Scholar
• Yadav VK, Oury F, Suda N, et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009;138(5):976-89
   PubMed Web of Science ®Google Scholar
• Wei J, Ducy P. Co-dependence of bone and energy metabolisms. Arch Biochem Biophys 2010;503(1):p.35-40
   Web of Science ®Google Scholar
• Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130(3):456-69
   PubMed Web of Science ®Google Scholar
• Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008;105(13):5266-70
   PubMed Web of Science ®Google Scholar
• Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010;142(2):296-308
   PubMed Web of Science ®Google Scholar
• Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69(3):990-1047
   PubMed Web of Science ®Google Scholar
• Price PA. Gla-containing proteins of bone. Connect Tissue Res 1989;21(1-4):51-7. discussion 57-60
   PubMed Web of Science ®Google Scholar
• Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382(6590):448-52
   PubMed Web of Science ®Google Scholar
• Murshed M, Schinke T, McKee MD, Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004;165(5):625-30
   PubMed Web of Science ®Google Scholar
• Martin TJ. A skeleton key to metabolism. Nat Med 2007;13(9):1021-3
   PubMed Web of Science ®Google Scholar
• Ferron M, McKee MD, Levine RL, et al. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012;50(2):568-75
   PubMed Web of Science ®Google Scholar
• Stafford DW. The vitamin K cycle. J Thromb Haemost 2005;3(8):1873-8
   PubMed Web of Science ®Google Scholar
• Poser JW, Esch FS, Ling NC, Price PA. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem 1980;255(18):8685-91
   PubMed Web of Science ®Google Scholar
• Ferron M, Lacombe J, Germain A, et al. GGCX and VKORC1 inhibit osteocalcin endocrine functions. J Cell Biol 2015;208(6):761-76
   PubMed Web of Science ®Google Scholar
• Shiba S, Ikeda K, Azuma K, et al. Gamma-Glutamyl carboxylase in osteoblasts regulates glucose metabolism in mice. Biochem Biophys Res Commun 2014;453(3):350-5
   PubMed Web of Science ®Google Scholar
• Ferron M, Wei J, Yoshizawa T, et al. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun 2010;397(4):691-6
   PubMed Web of Science ®Google Scholar
• Mauro LJ, Olmsted EA, Davis AR, Dixon JE. Parathyroid hormone regulates the expression of the receptor protein tyrosine phosphatase, OST-PTP, in rat osteoblast-like cells. Endocrinology 1996;137(3):925-33
   PubMed Web of Science ®Google Scholar
• Dacquin R, Mee PJ, Kawaguchi J, et al. Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Dev Dyn 2004;229(4):826-34
   PubMed Web of Science ®Google Scholar
• Hinoi E, Gao N, Jung DY, et al. The sympathetic tone mediates leptin’s inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 2008;183(7):1235-42
   PubMed Web of Science ®Google Scholar
• Yoshizawa T, Hinoi E, Jung DY, et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest 2009;119(9):2807-17
   PubMed Web of Science ®Google Scholar
• Rached MT, Kode A, Silva BC, et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 2010;120(1):357-68
   PubMed Web of Science ®Google Scholar
• Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010;142(2):309-19
   PubMed Web of Science ®Google Scholar
• Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89(2):309-19
   PubMed Web of Science ®Google Scholar
• Scimeca JC, Franchi A, Trojani C, et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 2000;26(3):207-13
   PubMed Web of Science ®Google Scholar
• Seifert MF, Marks SCJr. Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse. Am J Anat 1985;172(2):141-53
   PubMedGoogle Scholar
• Marks SCJr, Seifert MF, Lane PW. Osteosclerosis, a recessive skeletal mutation on chromosome 19 in the mouse. J Hered 1985;76(3):171-6
   PubMed Web of Science ®Google Scholar
• Lacombe J, Karsenty G, Ferron M. In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice. Mol Metab 2013;2(4):498-504
   PubMed Web of Science ®Google Scholar
• Faienza MF, Luce V, Ventura A, et al. Skeleton and glucose metabolism: a bone-pancreas loop. Int J Endocrinol 2015;2015:758148
   PubMed Web of Science ®Google Scholar
• Wei JW, Makinistoglu J, Maurizi A, et al. Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation. Cell 2015; In press
   Web of Science ®Google Scholar
• Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89(5):747-54
   PubMed Web of Science ®Google Scholar
• Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 1995;15(4):1858-69
   PubMed Web of Science ®Google Scholar
• Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423(6937):349-55
   PubMed Web of Science ®Google Scholar
• Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol 2009;25:629-48
   PubMed Web of Science ®Google Scholar
• Nilsson A, Ohlsson C, Isaksson OG, et al. Hormonal regulation of longitudinal bone growth. Eur J Clin Nutr 1994;48(Suppl 1):S150-8. discussion S158-60
   PubMedGoogle Scholar
• Raisz LG. Hormonal regulation of bone growth and remodelling. Ciba Found Symp 1988;136:226-38
   PubMedGoogle Scholar
• Canalis E. The hormonal and local regulation of bone formation. Endocr Rev 1983;4(1):62-77
   PubMed Web of Science ®Google Scholar
• Raisz LG, Canalis EM, Dietrich JW, et al. Hormonal regulation of bone formation. Recent Prog Horm Res 1978;34:335-56
   PubMedGoogle Scholar
• Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007;130(5):811-23
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton LJ3rd, Atkinson EJ, O’Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001;86(8):3555-61
   PubMed Web of Science ®Google Scholar
• Vandewalle S, Taes Y, Fiers T, et al. Associations of sex steroids with bone maturation, bone mineral density, bone geometry, and body composition: a cross-sectional study in healthy male adolescents. J Clin Endocrinol Metab 2014;99(7):E1272-82
   PubMed Web of Science ®Google Scholar
• Shiau HJ, Aichelmann-Reidy ME, Reynolds MA. Influence of sex steroids on inflammation and bone metabolism. Periodontol 2000;64(1):81-94
   Google Scholar
• Frenkel B, Hong A, Baniwal SK, et al. Regulation of adult bone turnover by sex steroids. J Cell Physiol 2010;224(2):305-10
   PubMed Web of Science ®Google Scholar
• Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res 2002;57:385-409
   PubMedGoogle Scholar
• Vanderschueren D, Vandenput L, Boonen S, et al. Androgens and bone. Endocr Rev 2004;25(3):389-425
   PubMed Web of Science ®Google Scholar
• Venken K, De Gendt K, Boonen S, et al. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J Bone Miner Res 2006;21(4):576-85
   PubMed Web of Science ®Google Scholar
• Oury F, Sumara G, Sumara O, et al. Endocrine regulation of male fertility by the skeleton. Cell 2011;144(5):796-809
   PubMed Web of Science ®Google Scholar
• Oury F, Ferron M, Huizhen W, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest 2013;123(6):2421-33
   PubMed Web of Science ®Google Scholar
• Buday B, Pach FP, Literati-Nagy B, et al. Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis. Bone 2013;57(1):98-104
   PubMed Web of Science ®Google Scholar
• Cui R, Su B, Sheng C, et al. Total osteocalcin in serum predicts testosterone level in male type 2 diabetes mellitus. Int J Clin Exp Med 2014;7(4):1145-9
   PubMed Web of Science ®Google Scholar
• Liao M, Guo X, Yu X, et al. Role of metabolic factors in the association between osteocalcin and testosterone in Chinese men. J Clin Endocrinol Metab 2013;98(8):3463-9
   PubMed Web of Science ®Google Scholar
• Kanazawa I, Tanaka K, Ogawa N, et al. Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus. Osteoporos Int 2013;24(3):1115-19
   PubMed Web of Science ®Google Scholar
• Kirmani S, Atkinson EJ, Melton LJ3rd, et al. Relationship of testosterone and osteocalcin levels during growth. J Bone Miner Res 2011;26(9):2212-16
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey A, Horne AM, Reid IR. Testosterone levels following decreases in serum osteocalcin. Calcif Tissue Int 2013;93(2):133-6
   PubMed Web of Science ®Google Scholar
• Pi M, Chen L, Huang MZ, et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. Plos One 2008;3(12):e3858
   Web of Science ®Google Scholar
• Wellendorph P, Hansen KB, Balsgaard A, et al. Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids. Mol Pharmacol 2005;67(3):589-97
   PubMed Web of Science ®Google Scholar
• Pi M, Faber P, Ekema G, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 2005;280(48):40201-9
   PubMed Web of Science ®Google Scholar
• Wellendorph P, Brauner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene 2004;335:37-46
   PubMed Web of Science ®Google Scholar
• Wei J, Hanna T, Suda N, et al. Osteocalcin promotes beta-cell proliferation during development and adulthood through Gprc6a. Diabetes 2014;63(3):1021-31
   PubMed Web of Science ®Google Scholar
• Pi M, Wu Y, Quarles LD. GPRC6A mediates responses to osteocalcin in beta-cells in vitro and pancreas in vivo. J Bone Miner Res 2011;26(7):1680-3
   PubMed Web of Science ®Google Scholar
• Kuang D, Yao Y, Lam J, et al. Cloning and characterization of a family C orphan G-protein coupled receptor. J Neurochem 2005;93(2):383-91
   PubMed Web of Science ®Google Scholar
• Pi M, Quarles LD. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks. Endocrinology 2012;153(5):2062-9
   PubMed Web of Science ®Google Scholar
• Boisen KA, Main KM, Rajpert-De Meyts E, et al. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann N Y Acad Sci 2001;948:90-9
   PubMed Web of Science ®Google Scholar
• Glass AR, Vigersky RA. Testicular reserve of testosterone precursors in primary testicular failure. Fertil Steril 1982;38(1):92-6
   PubMed Web of Science ®Google Scholar
• Paduch DA. Testicular cancer and male infertility. Curr Opin Urol 2006;16(6):419-27
   PubMed Web of Science ®Google Scholar
• Winters SJ, Troen P. A reexamination of pulsatile luteinizing hormone secretion in primary testicular failure. J Clin Endocrinol Metab 1983;57(2):432-5
   PubMed Web of Science ®Google Scholar
• Takenouchi T, Sato W, Torii C, Kosaki K. Progressive cognitive decline in an adult patient with cleidocranial dysplasia. Eur J Med Genet 2014;57(7):319-21
   PubMed Web of Science ®Google Scholar
• McBrien H, Turk J, Letch N. The management of ADHD and associated problems in a young person with cleidocranial dysostosis (CCD) and mild intellectual disability. Clin Child Psychol Psychiatry 2006;11(3):445-56
   PubMedGoogle Scholar
• Soule ABJr. Mutational dysostosis (cleidocranial dysostosis). J Bone Joint Surg Am 1946;28:81-102
   PubMed Web of Science ®Google Scholar
• Oury F, Khrimian L, Denny CA, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 2013;155(1):228-41
   PubMed Web of Science ®Google Scholar
• Yeap BB, Alfonso H, Chubb SA, et al. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab 2015;100(1):63-71
   PubMed Web of Science ®Google Scholar
• Chen X, Wu Y, Liu L, et al. Osteocalcin is inversely associated with glucose levels in middle-aged Tibetan men with different degrees of glucose tolerance. Diabetes Metab Res Rev 2014;30(6):476-82
   PubMed Web of Science ®Google Scholar
• Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009;25(8):768-72
   PubMed Web of Science ®Google Scholar
• Villafan-Bernal JR, Llamas-Covarrubias MA, Muñoz-Valle JF, et al. A cut-point value of uncarboxylated to carboxylated index is associated with glycemic status markers in type 2 diabetes. J Investig Med 2014;62(1):33-6
   PubMed Web of Science ®Google Scholar
• Iki M, Tamaki J, Fujita Y, et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int 2012;23(2):761-70
   PubMed Web of Science ®Google Scholar
• Zhou M, Ma X, Li H, et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009;161(5):723-9
   PubMed Web of Science ®Google Scholar
• Rui X, Xu B, Su J, et al. Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients. Med Sci Monit 2014;20:711-19
   PubMed Web of Science ®Google Scholar
• Iglesias P, Arrieta F, Piñera M, et al. Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance. Clin Endocrinol (Oxf) 2011;75(2):184-8
   PubMed Web of Science ®Google Scholar
• Lucey AJ, Paschos GK, Thorsdottir I, et al. Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein. Nutr Res 2013;33(1):67-75
   PubMed Web of Science ®Google Scholar
• Juanola-Falgarona M, Cándido-Fernández J, Salas-Salvadó J, et al. Association between serum ferritin and osteocalcin as a potential mechanism explaining the iron-induced insulin resistance. Plos One 2013;8(10):e76433
   Web of Science ®Google Scholar
• Lee SW, Jo HH, Kim MR, et al. Association between osteocalcin and metabolic syndrome in postmenopausal women. Arch Gynecol Obstet 2015. [Epub ahead of print]
   Web of Science ®Google Scholar
• El-Eshmawy M, Abdel Aal I. Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. Appl Physiol Nutr Metab 2015;40(3):218-22
   PubMed Web of Science ®Google Scholar
• Hu WW, Ke YH, He JW, et al. Serum osteocalcin levels are inversely associated with plasma glucose and body mass index in healthy Chinese women. Acta Pharmacol Sin 2014;35(12):1521-6
   PubMed Web of Science ®Google Scholar
• Kim YS, Nam JS, Yeo DW, et al. The effects of aerobic exercise training on serum osteocalcin, adipocytokines and insulin resistance on obese young males. Clin Endocrinol (Oxf) 2014;82(5):686-94
   PubMed Web of Science ®Google Scholar
• Kim GS, Jekal Y, Kim HS, et al. Reduced serum total osteocalcin is associated with central obesity in Korean children. Obes Res Clin Pract 2014;8(3):e201-98
   Web of Science ®Google Scholar
• Ngarmukos C, Chailurkit LO, Chanprasertyothin S, et al. A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort. Clin Endocrinol (Oxf) 2012;77(1):42-6
   PubMed Web of Science ®Google Scholar
• Yeap BB, Chubb SA, Flicker L, et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010;163(2):265-72
   PubMed Web of Science ®Google Scholar
• Confavreux CB, Szulc P, Casey R, et al. Lower serum osteocalcin is associated with more severe metabolic syndrome in elderly men from the MINOS cohort. Eur J Endocrinol 2014;171(2):275-83
   PubMed Web of Science ®Google Scholar
• Bezerra dos Santos Magalhaes K, Magalhães MM, Diniz ET, et al. Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. Ann Nutr Metab 2013;62(3):183-8
   PubMed Web of Science ®Google Scholar
• Prats-Puig A, Osiniri I, Soriano-Rodríguez P, et al. Undercarboxylated osteocalcin relates to cardiovascular risk markers in offspring of families with metabolic syndrome. Atherosclerosis 2014;233(1):272-7
   PubMed Web of Science ®Google Scholar
• Chin KY, Ima-Nirwana S, Mohamed IN, et al. Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men. Int J Med Sci 2014;11(2):151-7
   PubMed Web of Science ®Google Scholar
• Maddaloni E, D’Onofrio L, Lauria A, et al. Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes. J Endocrinol Invest 2014;37(7):661-6
   PubMed Web of Science ®Google Scholar
• Alfadda AA, Masood A, Shaik SA, et al. Association between osteocalcin, metabolic syndrome, and cardiovascular risk factors: role of total and undercarboxylated osteocalcin in patients with type 2 diabetes. Int J Endocrinol 2013;2013:197519
   PubMed Web of Science ®Google Scholar
• Oosterwerff MM, van Schoor NM, Lips P, Eekhoff EM. Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study. Clin Endocrinol (Oxf) 2013;78(2):242-7
   PubMed Web of Science ®Google Scholar
• Winhofer Y, Handisurya A, Tura A, et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 2010;33(1):139-43
   PubMed Web of Science ®Google Scholar
• Wei J, Ferron M, Clarke CJ, et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest 2014;124(4):1-13
   PubMed Web of Science ®Google Scholar
• Ferris HA, Kahn CR. New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it. J Clin Invest 2012;122(11):3854-7
   PubMed Web of Science ®Google Scholar
• Brennan-Speranza TC, Henneicke H, Gasparini SJ, et al. Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest 2012;122(11):4172-89
   PubMed Web of Science ®Google Scholar
• Zhou B, Li H, Liu J, et al. Intermittent injections of osteocalcin reverse autophagic dysfunction and endoplasmic reticulum stress resulting from diet-induced obesity in the vascular tissue via the NFkappaB-p65-dependent mechanism. Cell Cycle 2013;12(12):1901-13
   PubMed Web of Science ®Google Scholar
• Zhou B, Li H, Xu L, et al. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-kappaB signaling pathway. Endocrinology 2013;154(3):1055-68
   PubMed Web of Science ®Google Scholar
• Gupte AA, Sabek OM, Fraga D, et al. Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome. Endocrinology 2014;155(12):4697-705
   PubMed Web of Science ®Google Scholar
• Mizokami A, Yasutake Y, Higashi S, et al. Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion. Bone 2014;69:68-79
   PubMed Web of Science ®Google Scholar
• Mizokami A, Yasutake Y, Gao J, et al. Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. Plos One 2013;8(2):e57375
   Web of Science ®Google Scholar
• Riddle RC, Frey JL, Tomlinson RE, et al. Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis. Mol Cell Biol 2014;34(10):1850-62
   PubMed Web of Science ®Google Scholar
• Bozec A, Bakiri L, Jimenez M, et al. Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism. J Cell Sci 2013;126(Pt 23):5432-40
   PubMed Web of Science ®Google Scholar
• Yoshikawa Y, Kode A, Xu L, et al. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J Bone Miner Res 2011;26(9):2012-25
   PubMed Web of Science ®Google Scholar
• Makinistoglu MP, Karsenty G. The class II histone deacetylase HDAC4 regulates cognitive, metabolic and endocrine functions through its expression in osteoblasts. Mol Metab 2015;4(1):64-9
   PubMed Web of Science ®Google Scholar
• Gillespie JR, Bush JR, Bell GI, et al. GSK-3beta function in bone regulates skeletal development, whole-body metabolism, and male life span. Endocrinology 2013;154(10):3702-18
   PubMed Web of Science ®Google Scholar
• Lee NJ, Nguyen AD, Enriquez RF, et al. NPY signalling in early osteoblasts controls glucose homeostasis. Mol Metab 2015;4(3):164-74
   PubMed Web of Science ®Google Scholar